{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:51:32Z","timestamp":1789685492542,"version":"4.0.1"},"reference-count":101,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>In addition to kidney diseases characterized by the precipitation and deposition of overproduced monoclonal immunoglobulin and kidney damage due to chemotherapy agents, a broad spectrum of renal lesions may be found in patients with hematologic malignancies. Glomerular diseases, in the form of paraneoplastic glomerulopathies and acute kidney injury with various degrees of proteinuria due to specific lymphomatous interstitial and\/or glomerular infiltration, are two major renal complications observed in the lymphoid disorder setting. However, other hematologic neoplasms, including chronic lymphocytic leukemia, thymoma, myeloproliferative disorders, Castleman disease and hemophagocytic syndrome, have also been associated with the development of kidney lesions. These renal disorders require prompt recognition by the clinician, due to the need to implement specific treatment, depending on the chemotherapy regimen, to decrease the risk of subsequent chronic kidney disease. In the context of renal disease related to hematologic malignancies, renal biopsy remains crucial for accurate pathological diagnosis, with the aim of optimizing medical care for these patients. In this review, we provide an update on the epidemiology, clinical presentation, pathophysiological processes and diagnostic strategy for kidney diseases associated with hematologic malignancies outside the spectrum of monoclonal gammopathy of renal significance.<\/jats:p>","DOI":"10.3390\/diagnostics11040710","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T12:11:00Z","timestamp":1618488660000},"page":"710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits"],"prefix":"10.3390","volume":"11","author":[{"given":"Antoine","family":"Morel","sequence":"first","affiliation":[{"name":"Assistance Publique des H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux Universitaires Henri Mondor, Service de N\u00e9phrologie et Transplantation, Centre de R\u00e9f\u00e9rence Maladie Rare \u201cSyndrome N\u00e9phrotique Idiopathique\u201d, F\u00e9d\u00e9ration Hospitalo-Universitaire \u201cInnovative Therapy for Immune Disorders\u201d, 94000 Cr\u00e9teil, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U955, Institut Mondor de Recherche Biom\u00e9dicale (IMRB), Universit\u00e9 Paris Est Cr\u00e9teil, Equipe 21, 94000 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Sophie","family":"Meuleman","sequence":"additional","affiliation":[{"name":"Assistance Publique des H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux Universitaires Henri Mondor, Service de N\u00e9phrologie et Transplantation, Centre de R\u00e9f\u00e9rence Maladie Rare \u201cSyndrome N\u00e9phrotique Idiopathique\u201d, F\u00e9d\u00e9ration Hospitalo-Universitaire \u201cInnovative Therapy for Immune Disorders\u201d, 94000 Cr\u00e9teil, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U955, Institut Mondor de Recherche Biom\u00e9dicale (IMRB), Universit\u00e9 Paris Est Cr\u00e9teil, Equipe 21, 94000 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-3979","authenticated-orcid":false,"given":"Anissa","family":"Moktefi","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U955, Institut Mondor de Recherche Biom\u00e9dicale (IMRB), Universit\u00e9 Paris Est Cr\u00e9teil, Equipe 21, 94000 Cr\u00e9teil, France"},{"name":"D\u00e9partement de Pathologie, AP-HP, H\u00f4pitaux Universitaires Henri Mondor, 94000 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-2550","authenticated-orcid":false,"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[{"name":"Assistance Publique des H\u00f4pitaux de Paris (AP-HP), H\u00f4pitaux Universitaires Henri Mondor, Service de N\u00e9phrologie et Transplantation, Centre de R\u00e9f\u00e9rence Maladie Rare \u201cSyndrome N\u00e9phrotique Idiopathique\u201d, F\u00e9d\u00e9ration Hospitalo-Universitaire \u201cInnovative Therapy for Immune Disorders\u201d, 94000 Cr\u00e9teil, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U955, Institut Mondor de Recherche Biom\u00e9dicale (IMRB), Universit\u00e9 Paris Est Cr\u00e9teil, Equipe 21, 94000 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3322\/caac.21636","article-title":"Onconephrology: The intersections between the kidney and cancer","volume":"71","author":"Rosner","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ackd.2013.07.004","article-title":"Kidney involvement in leukemia and lymphoma","volume":"21","author":"Luciano","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrneph.2010.171","article-title":"Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis","volume":"7","author":"Lien","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.ajkd.2019.03.433","article-title":"Kidney complications of immune checkpoint inhibitors: A review","volume":"74","author":"Shingarev","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1681\/ASN.2018080853","article-title":"Therapeutic inhibition of VEGF signaling and associated nephrotoxicities","volume":"30","author":"Estrada","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","article-title":"Paraneoplastic glomerulopathies: New insights into an old entity","volume":"56","author":"Ronco","year":"1999","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2215\/CJN.03770412","article-title":"Onco-nephrology: Glomerular diseases with cancer","volume":"7","author":"Cambier","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ndt\/gfq427","article-title":"Renal involvement in Castleman disease","volume":"26","author":"Vuiblet","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"iii119","DOI":"10.1093\/ndt\/gfr245","article-title":"Renal involvement in a large cohort of Chinese patients with Castleman disease","volume":"27","author":"Xu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"Sticht","year":"2021","journal-title":"Histopathology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2009.73","article-title":"What nephrologists need to know about hemophagocytic syndrome","volume":"5","author":"Karras","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/bmj.296.6632.1295","article-title":"Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies","volume":"296","author":"Sawyer","year":"1988","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/ndt\/4.11.947","article-title":"Proteinuria and haematuria are frequently present in patients with lung cancer","volume":"4","author":"Puolijoki","year":"1989","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","article-title":"Kidney involvement and renal manifestations in non-Hodgkin\u2019s lymphoma and lymphocytic leukemia: A retrospective study in 700 patients","volume":"67","author":"Polliack","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, S.-J., Chen, H.-P., Chen, Y.-H., Zhang, L.-H., Tu, Y.-M., and Liu, Z.-H. (2014). Renal involvement in non-hodgkin lymphoma: Proven by renal biopsy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095190"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Poitou-Verkinder, A.-L., Francois, A., Drieux, F., Lepretre, S., Legallicier, B., Moulin, B., Godin, M., and Guerrot, D. (2015). The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia \/ small lymphocytic lymphoma: A 25-year multicenter experience. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119156"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","article-title":"Glomerular diseases seen with cancer and chemotherapy: A narrative review","volume":"84","author":"Jhaveri","year":"2013","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ckj\/sfy026","article-title":"Renal involvement in chronic lymphocytic leukemia","volume":"11","author":"Wanchoo","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1681\/ASN.V881348","article-title":"Acute renal failure due to lymphomatous infiltration of the kidneys","volume":"8","author":"Obrador","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","first-page":"147","article-title":"Renal involvement in myeloproliferative and lymphoproliferative disorders","volume":"142","author":"Xiao","year":"1997","journal-title":"A study of autopsy cases. Gen. Diagn. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kint.2019.01.027","article-title":"Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders","volume":"96","author":"Javaugue","year":"2019","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.ki.5000352","article-title":"Nephrotic syndrome associated with hemophagocytic syndrome","volume":"69","author":"Thaunat","year":"2006","journal-title":"Kidney Int."},{"key":"ref_28","first-page":"305","article-title":"Glomerular involvement in lymphoproliferative disorders with hyperproduction of cytokines (Castleman, POEMS)","volume":"30","author":"Rieu","year":"2000","journal-title":"Adv. Nephrol. Necker Hosp."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease: Clinical findings and clinicopathologic correlations in 15 patients","volume":"3","author":"Frizzera","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma","volume":"4","author":"Schmitz","year":"2009","journal-title":"Ann. Rev. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0002-9343(71)90205-1","article-title":"Acute nephrotic syndrome as a manifestation of active Hodgkin\u2019s disease","volume":"50","author":"Plager","year":"1971","journal-title":"Am. J. Med."},{"key":"ref_32","first-page":"114","article-title":"Nephrotic syndrome in Hodgkin\u2019s disease. Report of five cases and review of the literature","volume":"24","author":"Kramer","year":"1981","journal-title":"Neth. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.1977.47","article-title":"Glomerulopathies of neoplasia","volume":"11","author":"Eagen","year":"1977","journal-title":"Kidney Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: Report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2007.06.021","article-title":"Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease","volume":"50","author":"Aggarwal","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9343(76)90325-9","article-title":"Nephrotic syndrome in Hodgkin\u2019s disease. Evidence for pathogenesis alternative to immune complex deposition","volume":"61","author":"Moorthy","year":"1976","journal-title":"Am. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000313947","article-title":"Immunopathogenesis of idiopathic nephrotic syndrome with relapse","volume":"169","author":"Zhang","year":"2011","journal-title":"Contrib. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1084\/jem.189.12.1939","article-title":"Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells","volume":"189","author":"Kapp","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood.V97.1.250","article-title":"Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"97","author":"Skinnider","year":"2001","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V113413","article-title":"Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells","volume":"11","author":"Aten","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change\u2014Like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.humpath.2010.01.021","article-title":"Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor \u03b1 in Hodgkin-Reed-Sternberg cells","volume":"41","author":"Nakayama","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-013-0415-3","article-title":"Immunopathogenesis of idiopathic nephrotic syndrome with relapse","volume":"36","author":"Sahali","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","article-title":"Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes","volume":"115","author":"Audard","year":"2010","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MD.0000000000000206","article-title":"Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: A retrospective study of 18 cases","volume":"93","author":"Kofman","year":"2014","journal-title":"Medicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3324\/haematol.2015.128793","article-title":"Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: The Mayo Clinic experience","volume":"100","author":"Strati","year":"2015","journal-title":"Haematologica"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.1992.270","article-title":"Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas","volume":"42","author":"Moulin","year":"1992","journal-title":"Kidney Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0140-6736(57)91736-1","article-title":"Leukaemia","volume":"272","author":"Scott","year":"1957","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archinte.1986.00360130167023","article-title":"A review of nephrotic syndrome associated with chronic lymphocytic leukemia","volume":"146","author":"Seney","year":"1986","journal-title":"Arch Intern. Med."},{"key":"ref_51","first-page":"317","article-title":"Monoclonal B lymphocytosis and minimal change disease: A new monoclonal B-cell disorder of renal significance?","volume":"31","author":"Lenain","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.revmed.2018.05.006","article-title":"Chronic lymphoid leukemia and renal complication: Report on 10 cases from Marseille over 16 years","volume":"39","author":"Vial","year":"2018","journal-title":"Rev. Med. Interne"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.2019000725","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"134","author":"Dimopoulos","year":"2019","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2215\/CJN.01600408","article-title":"Renal lesions associated with IgM-secreting monoclonal proliferations: Revisiting the disease spectrum","volume":"3","author":"Audard","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.ajkd.2015.03.035","article-title":"Kidney diseases associated with monoclonal immunoglobulin M\u2013secreting B-cell lymphoproliferative disorders: A case series of 35 patients","volume":"66","author":"Chauvet","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2215\/CJN.13041117","article-title":"Kidney involvement of patients with Waldenstr\u00f6m macroglobulinemia and other IgM-producing B cell lymphoproliferative disorders","volume":"13","author":"Higgins","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.14279","article-title":"Renal disease related to Waldenstr\u00f6m macroglobulinaemia: Incidence, pathology and clinical outcomes","volume":"175","author":"Vos","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_58","first-page":"41","article-title":"Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma\u2014A case report and review of the literature","volume":"10","author":"Torres","year":"2018","journal-title":"Leuk. Res. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00277-012-1547-6","article-title":"Renal failure secondary to leukemic infiltration of kidneys in CLL\u2014A case report and review of literature","volume":"92","author":"Uprety","year":"2013","journal-title":"Ann. Hematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ekir.2019.02.008","article-title":"Renal dysfunction in patients with direct infiltration by B-cell lymphoma","volume":"4","author":"Corlu","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ajkd.2003.08.004","article-title":"Lymphomas diagnosed by percutaneous kidney biopsy","volume":"42","author":"Heiro","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e4391","DOI":"10.1097\/MD.0000000000004391","article-title":"Monotypic plasma cell interstitial nephritis as the only clinical manifestation in a patient with previously undiagnosed indolent multiple myeloma: A case report","volume":"95","author":"Attias","year":"2016","journal-title":"Medicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative neoplasms","volume":"376","author":"Spivak","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.leukres.2014.01.014","article-title":"Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms","volume":"38","author":"Christensen","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2017.06.009","article-title":"Acute renal infarction: A presentation of essential thrombocytosis","volume":"92","author":"Kayar","year":"2017","journal-title":"Kidney Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","article-title":"Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: A systematic review and meta-analysis","volume":"3","author":"Carobbio","year":"2019","journal-title":"Blood Adv."},{"key":"ref_68","first-page":"5","article-title":"Bone marrow fibrosis in primary myelofibrosis: Pathogenic mechanisms and the role of TGF-\u03b2","volume":"3","author":"Agarwal","year":"2016","journal-title":"Stem Cell Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humpath.2006.12.011","article-title":"Increased angiogenesis in chronic idiopathic myelofibrosis: Vascular endothelial growth factor as a prominent angiogenic factor","volume":"38","author":"Steurer","year":"2007","journal-title":"Hum. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1523-1755.2005.00574.x","article-title":"The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis","volume":"68","author":"Wada","year":"2005","journal-title":"Kidney Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI200112367","article-title":"Apoptosis in podocytes induced by TGF-beta and Smad7","volume":"108","author":"Schiffer","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ekir.2020.12.005","article-title":"Kidney involvement in patients with chronic myelomonocytic leukemia or BCR-ABL\u2013Negative myeloproliferative neoplasms","volume":"6","author":"Belliere","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: Interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.revmed.2014.04.004","article-title":"Auto-immune diseases and cancers. Second part: Auto-immune diseases complicating cancers and their treatment","volume":"35","author":"Pasquet","year":"2014","journal-title":"Rev. Med. Interne"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<200::AID-AJH6>3.0.CO;2-0","article-title":"Myelodysplastic syndromes with nephrotic syndrome","volume":"60","author":"Saitoh","year":"1999","journal-title":"Am. J. Hematol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.leukres.2005.08.025","article-title":"The 5q- syndrome and autoimmune phenomena: Report of three cases","volume":"30","author":"Pinheiro","year":"2006","journal-title":"Leuk. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10428199509059648","article-title":"Glomerular injury in chronic myelomonocytic leukemia","volume":"18","author":"Morschhauser","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s004670100025","article-title":"Glomerular involvement in myelodysplastic syndromes","volume":"16","author":"Stajic","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ekir.2020.12.030","article-title":"Spectrum of kidney involvement in patients with myelodysplastic syndromes","volume":"6","author":"Schwotzer","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10157-011-0499-9","article-title":"Renal complications of Castleman\u2019s disease: Report of two cases and analysis of 75 cases","volume":"15","author":"Yuan","year":"2011","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/asheducation-2018.1.318","article-title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","volume":"2018","author":"Fajgenbaum","year":"2018","journal-title":"Hematology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12882-019-1574-9","article-title":"TAFRO syndrome as a cause of glomerular microangiopathy: A case report and literature review","volume":"20","author":"Nagayama","year":"2019","journal-title":"BMC Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ekir.2020.05.004","article-title":"The clinical and histopathological feature of renal manifestation of TAFRO syndrome","volume":"5","author":"Mizuno","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: Definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"ref_87","first-page":"685","article-title":"Kidney involvement in hematologic malignancies. Diagnostic approach","volume":"31","author":"Dussol","year":"2010","journal-title":"Rev. Med. Interne"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/ndt\/14.10.2370","article-title":"A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome","volume":"14","author":"Nakamoto","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e9920","DOI":"10.1097\/MD.0000000000009920","article-title":"A case report of POEMS syndrome with renal involvement as immunotactoid glomerulopathy","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"ref_90","first-page":"482","article-title":"Association of a POEMS syndrome and light chain deposit disease: First case report","volume":"55","author":"Lambotte","year":"2001","journal-title":"Clin. Nephrol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka","year":"2007","journal-title":"Blood Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2215\/CJN.00590120","article-title":"Malaria, Collapsing glomerulopathy, and focal and segmental glomerulosclerosis","volume":"15","author":"Amoura","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.ajkd.2015.11.017","article-title":"Hemophagocytic syndrome with histiocytic glomerulopathy and intraglomerular hemophagocytosis","volume":"67","author":"Santoriello","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ckj\/sfv010","article-title":"Histiocytic glomerulopathy associated with macrophage activation syndrome","volume":"8","author":"Eirin","year":"2015","journal-title":"Clin. Kidney J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fneur.2020.00604","article-title":"A practical approach to managing patients with Myasthenia Gravis\u2014Opinions and a review of the literature","volume":"11","author":"Farrugia","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: A potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ndt\/gfh615","article-title":"Renal and thymic pathology in thymoma-associated nephropathy: Report of 21 cases and review of the literature","volume":"20","author":"Karras","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1523-1755.2005.00664.x","article-title":"Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo\/Mna rats","volume":"68","author":"Buzelin","year":"2005","journal-title":"Kidney Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI0212858","article-title":"Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats","volume":"109","author":"Godfrin","year":"2002","journal-title":"J. Clin. Investig."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/4\/710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:48:31Z","timestamp":1760161711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/4\/710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":101,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["diagnostics11040710"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics11040710","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}